客户简介

Shangyao Kangdele (Shanghai) Pharmaceutical Co., Ltd

Shangyao Kangdeli, formerly a wholly-owned company of Cardinal Health in China, has been at the forefront of imported drugs and medical devices in the Chinese market for many years. In February 2018, it was integrated into Shanghai Pharmaceutical Group and managed by Shanghai Pharmaceutical Holdings Co., Ltd. Shangyao Kangdeli actively seizes and expands the huge business opportunities in the global pharmaceutical and medical device industry, creates innovative medical and pharmaceutical business models, and better serves patients and consumers. Focusing on the vision of Shanghai Pharmaceutical Holdings' commitment to developing into a technologically competitive health service enterprise with international competitiveness, Shanghai Pharmaceutical Kangdeli continuously explores and optimizes integrated import services and solutions, further consolidating Shanghai Pharmaceutical Holdings' position as a pharmaceutical import platform nationwide.